Catalia Health is a San Francisco–based patient care management company founded in 2014 that offers an AI-powered personal healthcare companion called Mabu. The platform combines artificial intelligence, psychology and medical best practices to support patients managing chronic illnesses and to deliver daily, tailored check-ins. Mabu is deployed to help patients with conditions such as rheumatoid arthritis, late-stage kidney disease and congestive heart failure and to provide clinicians insight on adherence and patient status. Catalia positions its technology against a U.S. population of roughly 117 million people managing chronic conditions and targets improved medication adherence, symptom management and reduced readmissions. The company announced a hire for Director of Product Management to oversee the platform roadmap as it prepares clinical and commercial rollout. Catalia Health provides an AI-powered patient engagement platform that pairs proprietary conversation-generation algorithms with a social robot, Mabu, to engage patients, collect data, and support care management. The platform targets chronic-disease management and medication adherence, aiming to improve symptom management and reduce hospital readmissions. Catalia plans to build and deploy its care management system across its first three disease states and begin patient rollout in its first two disease states in early summer 2017. The company emphasizes scalable, personalized conversations to increase adherence and monitor patient health. Catalia was founded in 2014 and is based in San Francisco; Dr. Cory Kidd is CEO and founder. Financially, the company has completed a seed extension following an earlier seed round to fund product deployment and data collection. Catalia Health develops Mabu, a social robot designed to provide information and support for patients with chronic diseases such as diabetes, arthritis, cancer and heart disease. The company is pitching Mabu to healthcare providers and pharmaceutical companies to augment doctors and help manage large patient populations. Catalia has an alpha prototype in its offices and plans to scale production and deployment. The firm expects to have the first robots on the market by the end of the year and is already in discussions with several early potential customers. Founded by Cory Kidd using work that began at MIT’s Media Lab and evolved through his prior company Intuitive Automata, Catalia is positioning Mabu around engagement and the psychology of interaction. The company will use the recent financing to scale up its business.

Total raised

$8M

Funding rounds

3

Latest round

Series A

Latest activity

Nov 2017